Chemed Corporation $CHE Position Cut by Fort Washington Investment Advisors Inc. OH

Fort Washington Investment Advisors Inc. OH decreased its position in shares of Chemed Corporation (NYSE:CHE) by 7.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 51,766 shares of the company’s stock after selling 4,213 shares during the quarter. Fort Washington Investment Advisors Inc. OH owned about 0.37% of Chemed worth $22,149,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of the company. Smartleaf Asset Management LLC lifted its position in Chemed by 71.4% in the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock valued at $27,000 after purchasing an additional 25 shares during the last quarter. First Horizon Corp bought a new position in Chemed in the 3rd quarter worth about $31,000. Pilgrim Partners Asia Pte Ltd acquired a new stake in shares of Chemed in the third quarter valued at approximately $45,000. HM Payson & Co. raised its holdings in shares of Chemed by 35.5% during the third quarter. HM Payson & Co. now owns 103 shares of the company’s stock valued at $46,000 after buying an additional 27 shares during the last quarter. Finally, Geneos Wealth Management Inc. raised its holdings in shares of Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after buying an additional 76 shares during the last quarter. Institutional investors own 95.85% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently commented on CHE. Royal Bank Of Canada restated a “sector perform” rating and issued a $422.00 target price (down from $572.00) on shares of Chemed in a research report on Friday, February 27th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Oppenheimer lowered their price target on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th. Jefferies Financial Group cut shares of Chemed from a “buy” rating to a “hold” rating in a research note on Thursday, January 22nd. Finally, Zacks Research downgraded shares of Chemed from a “hold” rating to a “strong sell” rating in a report on Wednesday, March 4th. Two equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $498.00.

Chemed Price Performance

Shares of NYSE:CHE opened at $368.42 on Friday. Chemed Corporation has a 12 month low of $365.20 and a 12 month high of $623.60. The stock has a market cap of $5.07 billion, a price-to-earnings ratio of 20.06, a PEG ratio of 1.47 and a beta of 0.46. The stock’s 50 day moving average price is $428.15 and its 200 day moving average price is $435.53.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Wednesday, February 25th. The company reported $6.42 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.02 by ($0.60). Chemed had a net margin of 10.48% and a return on equity of 25.66%. The firm had revenue of $639.34 million for the quarter, compared to the consensus estimate of $659.09 million. During the same period in the previous year, the business posted $6.83 earnings per share. The business’s revenue for the quarter was down .1% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. On average, sell-side analysts expect that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 13th. Investors of record on Monday, February 23rd were paid a dividend of $0.60 per share. The ex-dividend date of this dividend was Monday, February 23rd. This represents a $2.40 annualized dividend and a yield of 0.7%. Chemed’s dividend payout ratio (DPR) is currently 13.06%.

Insider Transactions at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Thursday, March 12th. The stock was sold at an average price of $403.18, for a total transaction of $806,360.00. Following the transaction, the chief executive officer directly owned 93,719 shares of the company’s stock, valued at $37,785,626.42. The trade was a 2.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 3.29% of the stock is currently owned by insiders.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.